Arlington, MA, United States of America

David V Erbe

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Boston, MA (US) (2009)
  • Arlington, MA (US) (2010 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David V. Erbe

Introduction

David V. Erbe, an esteemed inventor based in Arlington, Massachusetts, has made significant advancements in the field of biotechnology. With a remarkable portfolio of 10 patents, he has played a vital role in developing innovative therapeutic solutions aimed at treating various medical conditions.

Latest Patents

Among his notable inventions, two recent patents stand out. The first is concerning Glucokinase (GCK) iRNA compositions and methods of use thereof. This invention involves double-stranded ribonucleic acid (dsRNA) compositions that target the glucokinase (GCK) gene. It outlines methods for inhibiting the expression of this gene and offers potential treatment options for individuals affected by glycogen storage diseases (GSD), specifically type Ia GSD. The second patent focuses on IL-6 antagonists and their uses. This invention provides specific antagonists for binding to site II of Interleukin-6 (IL-6), along with methods for utilizing these inhibitors to treat IL-6 related diseases, including diabetic macular edema, a condition affecting the eye.

Career Highlights

Throughout his career, David has contributed his expertise to prominent companies, including Alnylam Pharmaceuticals, Inc. and Wyeth, where he has been instrumental in bringing innovative biopharmaceutical products to market. His work is characterized by a commitment to addressing complex health challenges through cutting-edge research and development.

Collaborations

David V. Erbe has collaborated with esteemed colleagues in his field, including Kevin Fitzgerald and Jinbo Lee. Their collective efforts have advanced the scientific understanding of interleukins and RNA interference, resulting in significant progress in therapeutic interventions.

Conclusion

In conclusion, David V. Erbe’s contributions to innovation in biotechnology, through his valuable patents and collaborations, highlight the importance of sustained research efforts in advancing medical treatments. His work continues to inspire future generations of inventors and researchers aiming to transform health care solutions globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…